Income Statement GeNeuro SA

Equities

GNRO

CH0308403085

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-01-23 am EST			5-day change	1st Jan Change
0.0308 ^EUR	0.00%		-4.35%	-1.91%

Jan. 23	GeNeuro Requests Trading Halt on Euronext Paris Pending Debt Moratorium Ruling	MT
Jan. 23	GeNeuro Suspends Trading in Paris

8e0e82e94476c40e357.0iqMK1y-sYgoUIK4izlvygAdXyi8Pr9uZIXfu0aobGk.nRLmRBDs--IbJsaP8WYw52hwCH-EYccLFcKH5A7lNi2aE-0Tcf3y_VJh2w

Published financial data: GENEURO SA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	-	-	-	-	-
Other Revenues, Total	-	-	-	-	-
Total Revenues	-	-	-	-	-
Gross Profit	-	-	-	-	-
Selling General & Admin Expenses, Total	3.76M	3.3M	2.68M	3.25M	3.05M
Stock-Based Compensation (IS)	-	1.36M	-	589K	-
R&D Expenses	5.22M	4.12M	3.66M	7.97M	11.3M
Other Operating Expenses	10.3K	38.2K	23.8K	12.7K	1.5K
Other Operating Expenses, Total	8.99M	8.82M	6.37M	11.82M	14.36M
Operating Income	-8.99M	-8.82M	-6.37M	-11.82M	-14.36M
Interest Expense, Total	-442K	-72.3K	-	-	-
Interest And Investment Income	5.9K	-	-	7.6K	75.9K
Net Interest Expenses	-436K	-72.3K	-	7.6K	75.9K
Currency Exchange Gains (Loss)	-28.1K	-61.7K	53.9K	-118K	-326K
Other Non Operating Income (Expenses)	-6.5K	-4.8K	-506K	-269K	-146K
EBT, Excl. Unusual Items	-9.46M	-8.96M	-6.82M	-12.2M	-14.75M
EBT, Incl. Unusual Items	-9.46M	-8.96M	-6.82M	-12.2M	-14.75M
Income Tax Expense	-	-	-	2.1K	4.2K
Earnings From Continuing Operations	-9.46M	-8.96M	-6.82M	-12.2M	-14.76M
Net Income to Company	-9.46M	-8.96M	-6.82M	-12.2M	-14.76M
Net Income - (IS)	-9.46M	-8.96M	-6.82M	-12.2M	-14.76M
Net Income to Common Incl Extra Items	-9.46M	-8.96M	-6.82M	-12.2M	-14.76M
Net Income to Common Excl. Extra Items	-9.46M	-8.96M	-6.82M	-12.2M	-14.76M
Per Share Items
Net EPS - Basic	-0.65	-0.45	-0.32	-0.51	-0.59
Basic EPS - Continuing Operations	-0.65	-0.45	-0.32	-0.51	-0.59
Basic Weighted Average Shares Outstanding	14.56M	19.97M	21.28M	23.9M	24.84M
Net EPS - Diluted	-0.65	-0.45	-0.32	-0.51	-0.59
Diluted EPS - Continuing Operations	-0.65	-0.45	-0.32	-0.51	-0.59
Diluted Weighted Average Shares Outstanding	14.56M	19.97M	21.28M	23.9M	24.84M
Normalized Basic EPS	-0.41	-0.28	-0.2	-0.32	-0.37
Normalized Diluted EPS	-0.41	-0.28	-0.2	-0.32	-0.37
Supplemental Items
EBITDA	-8.95M	-8.77M	-6.32M	-11.78M	-14.32M
EBITA	-8.99M	-8.82M	-6.37M	-11.82M	-14.36M
EBIT	-8.99M	-8.82M	-6.37M	-11.82M	-14.36M
EBITDAR	-8.9M	-8.7M	-6.24M	-11.7M	-14.24M
Effective Tax Rate - (Ratio)	-	-	-	-0.02	-0.03
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-5.91M	-5.6M	-4.26M	-7.62M	-9.22M
Interest on Long-Term Debt	-	9.1K	-	-	-
Non-Cash Pension Expense	86.5K	19.2K	-400K	51.9K	-83.8K
Supplemental Operating Expense Items
General and Administrative Expenses	3.7M	3.23M	2.59M	3.17M	2.97M
Research And Development Expense From Footnotes	6.17M	4.71M	4.89M	9.83M	12.49M
Net Rental Expense, Total	46.2K	77.1K	82.9K	80.8K	82.7K
Imputed Operating Lease Interest Expense	37.57K	8.85K	-	-	-
Imputed Operating Lease Depreciation	8.63K	68.25K	-	-	-
Stock-Based Comp., R&D Exp. (Total)	60.2K	37.6K	40.7K	60.7K	57.3K
Stock-Based Comp., G&A Exp. (Total)	22.7K	68.9K	106K	174K	188K
Stock-Based Comp., Other (Total)	300	1.36M	100	589K	-
Total Stock-Based Compensation	83.2K	1.47M	147K	824K	245K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	5.93M	6.84M	5.48M	5.59M	1.83M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	5.93M	6.84M	5.48M	5.59M	1.83M
Other Receivables	975K	609K	1.17M	1.37M	-
Notes Receivable	-	-	-	-	-
Total Receivables	975K	609K	1.17M	1.37M	-
Prepaid Expenses	173K	80.3K	70K	34.2K	64.8K
Other Current Assets, Total	202K	130K	3.15M	2.09M	442K
Total Current Assets	7.28M	7.66M	9.87M	9.09M	2.33M
Gross Property Plant And Equipment	1.41M	2.37M	2.42M	2.48M	2.52M
Accumulated Depreciation	-729K	-931K	-1.2M	-1.49M	-1.78M
Net Property Plant And Equipment	678K	1.44M	1.22M	993K	742K
Other Intangibles, Total	1.16M	1.15M	1.14M	1.14M	1.15M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	286K	257K	309K	250K	2.13M
Total Assets	9.4M	10.51M	12.54M	11.47M	6.36M
Liabilities
Accounts Payable, Total	1.25M	540K	581K	765K	2.46M
Accrued Expenses, Total	899K	1.48M	1.63M	1.66M	3.02M
Short-term Borrowings	7.69M	-	-	-	-
Current Portion of Long-Term Debt	7.5K	49.2K	106K	328K	449K
Current Portion of Leases	329K	244K	257K	274K	298K
Unearned Revenue Current, Total	-	-	468K	254K	-
Other Current Liabilities	810K	9.2K	29.1K	28.8K	20.9K
Total Current Liabilities	10.98M	2.33M	3.07M	3.31M	6.25M
Long-Term Debt	183K	130K	2.58M	5.79M	12.42M
Long-Term Leases	300K	1.14M	959K	731K	498K
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	3.14M	1.39M	1.08M	154K	928K
Other Non Current Liabilities	6.8K	3.4K	11.1K	26K	42.6K
Total Liabilities	14.61M	5M	7.69M	10.01M	20.14M
Common Stock, Total	615K	892K	972K	1.1M	1.1M
Additional Paid In Capital	53.65M	14.7M	20.24M	27.16M	33.6K
Retained Earnings	-57.43M	-10.02M	-58.2M	-69.58M	-56.97M
Treasury Stock	-	-	-726K	-795K	-796K
Comprehensive Income and Other	-2.04M	-58.2K	42.56M	43.58M	42.85M
Total Common Equity	-5.21M	5.51M	4.85M	1.46M	-13.78M
Total Equity	-5.21M	5.51M	4.85M	1.46M	-13.78M
Total Liabilities And Equity	9.4M	10.51M	12.54M	11.47M	6.36M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.48M	20.47M	22.19M	24.86M	29.6M
ECS Total Common Shares Outstanding	14.55M	20.45M	22.19M	24.84M	24.83M
Book Value / Share	-0.36	0.27	0.22	0.06	-0.55
Tangible Book Value	-6.36M	4.37M	3.7M	324K	-14.93M
Tangible Book Value Per Share	-0.44	0.21	0.17	0.01	-0.6
Total Debt	8.51M	1.57M	3.9M	7.12M	13.67M
Net Debt	2.58M	-5.28M	-1.58M	1.53M	11.84M
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.14M	1.39M	1.08M	154K	928K
Debt Equivalent Oper. Leases	370K	617K	663K	646K	662K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	525K	480K	520K	578K	590K
Full Time Employees	24	17	16	19	17

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-9.46M	-8.96M	-6.82M	-12.2M	-14.76M
Depreciation & Amortization - CF	347K	354K	290K	286K	294K
Depreciation & Amortization, Total	347K	354K	290K	286K	294K
Amortization of Deferred Charges, Total - (CF)	8.1K	8.2K	9.8K	2.4K	-
(Gain) Loss From Sale Of Asset	-	700	-	-	-
Stock-Based Compensation (CF)	83.2K	1.47M	614K	824K	245K
Other Operating Activities, Total	520K	408K	-398K	-93.2K	122K
Change In Accounts Receivable	-	-	-	-	-
Change In Accounts Payable	-4.08M	-707K	37K	160K	1.76M
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	2.69M	255K	-507K	-2.04M	2.19M
Cash from Operations	-9.89M	-7.17M	-6.77M	-13.06M	-10.15M
Capital Expenditure	-50.4K	-21.4K	-40.4K	-57.4K	-12.5K
Sale (Purchase) of Intangible assets	-	-1.9K	-3.2K	-	-12.5K
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	4K	500	-	7.5K	75.8K
Cash from Investing	-46.4K	-22.8K	-43.6K	-49.9K	50.8K
Long-Term Debt Issued, Total	7.5M	-	-	6.46M	6.92M
Total Debt Issued	7.5M	-	-	6.46M	6.92M
Short Term Debt Repaid, Total	-	-15K	-	-	-
Long-Term Debt Repaid, Total	-315K	-328K	-230K	-387K	-567K
Total Debt Repaid	-315K	-343K	-230K	-387K	-567K
Issuance of Common Stock	-	10M	6.02M	7.66M	-
Repurchase of Common Stock	-	-80K	-	-	-
Other Financing Activities, Total	-249K	-1.43M	-415K	-637K	-34.8K
Cash from Financing	6.94M	8.15M	5.38M	13.1M	6.32M
Foreign Exchange Rate Adjustments	-26.8K	-40.9K	74.1K	126K	7.1K
Net Change in Cash	-3.03M	912K	-1.36M	114K	-3.77M
Supplemental Items
Cash Interest Paid	249K	260K	13.8K	18.6K	34.8K
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-6.83M	-4.14M	-6.47M	-5.43M	-2.68M
Unlevered Free Cash Flow	-6.55M	-4.1M	-6.47M	-5.43M	-2.68M
Change In Net Working Capital	1.32M	392K	2.9M	-897K	-5.78M
Net Debt Issued / Repaid	7.18M	-343K	-230K	6.08M	6.36M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-47.92	-55.4	-34.52	-61.53	-100.64
Return on Total Capital	-124.29	-106.24	-50.28	-85.25	-211.83
Return On Equity %	-5.46K	-5.86K	-131.62	-386.76	239.67
Return on Common Equity	-5.46K	-5.86K	-131.62	-386.76	239.67
Margin Analysis
Gross Profit Margin %	-	-	-	-	-
SG&A Margin	-	-	-	-	-
EBITDA Margin %	-	-	-	-	-
EBITA Margin %	-	-	-	-	-
EBIT Margin %	-	-	-	-	-
Income From Continuing Operations Margin %	-	-	-	-	-
Net Income Margin %	-	-	-	-	-
Net Avail. For Common Margin %	-	-	-	-	-
Normalized Net Income Margin	-	-	-	-	-
Levered Free Cash Flow Margin	-	-	-	-	-
Unlevered Free Cash Flow Margin	-	-	-	-	-
Asset Turnover
Asset Turnover	-	-	-	-	-
Fixed Assets Turnover	-	-	-	-	-
Short Term Liquidity
Current Ratio	0.66	3.29	3.22	2.75	0.37
Quick Ratio	0.63	3.2	2.17	2.11	0.29
Operating Cash Flow to Current Liabilities	-0.9	-3.08	-2.21	-3.95	-1.62
Long Term Solvency
Total Debt/Equity	-163.37	28.41	80.5	486.42	-99.19
Total Debt / Total Capital	257.81	22.12	44.6	82.95	-12.29K
LT Debt/Equity	-9.28	23.09	73.01	445.3	-93.77
Long-Term Debt / Total Capital	14.65	17.98	40.45	75.94	-11.62K
Total Liabilities / Total Assets	155.41	47.53	61.36	87.24	316.57
EBIT / Interest Expense	-20.34	-122.04	-	-	-
EBITDA / Interest Expense	-19.56	-117.15	-	-	-
(EBITDA - Capex) / Interest Expense	-19.67	-117.45	-	-	-
Total Debt / EBITDA	-0.98	-0.18	-0.64	-0.62	-0.97
Net Debt / EBITDA	-0.3	0.62	0.26	-0.13	-0.84
Total Debt / (EBITDA - Capex)	-0.98	-0.18	-0.64	-0.61	-0.97
Net Debt / (EBITDA - Capex)	-0.3	0.62	0.26	-0.13	-0.84
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	-
Gross Profit, 1 Yr. Growth %	-	-	-	-	-
EBITDA, 1 Yr. Growth %	11.36	-1.93	-14.7	73.53	21.55
EBITA, 1 Yr. Growth %	11.15	-1.85	-14.66	72.96	21.48
EBIT, 1 Yr. Growth %	11.15	-1.85	-14.66	72.96	21.48
Earnings From Cont. Operations, 1 Yr. Growth %	13.6	-5.27	-23.93	78.94	20.96
Net Income, 1 Yr. Growth %	13.6	-5.27	-23.93	78.94	20.96
Normalized Net Income, 1 Yr. Growth %	13.6	-5.27	-23.93	78.91	20.95
Diluted EPS Before Extra, 1 Yr. Growth %	13.79	-30.77	-28.8	59.34	16.36
Net Property, Plant and Equip., 1 Yr. Growth %	572.79	112.84	-15.51	-18.51	-25.26
Total Assets, 1 Yr. Growth %	-33.11	11.83	19.3	-8.53	-44.54
Tangible Book Value, 1 Yr. Growth %	-244.9	-168.6	-15.18	-91.25	-4.71K
Common Equity, 1 Yr. Growth %	-193.76	-205.88	-12.14	-69.79	-1.04K
Cash From Operations, 1 Yr. Growth %	-43.57	-27.49	-5.61	92.9	-22.31
Capital Expenditures, 1 Yr. Growth %	65.25	-57.54	88.78	42.08	-78.22
Levered Free Cash Flow, 1 Yr. Growth %	-54.4	-39.35	39.09	-13.72	-50.75
Unlevered Free Cash Flow, 1 Yr. Growth %	-56.24	-37.49	40.45	-13.72	-50.75
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	-
Gross Profit, 2 Yr. CAGR %	-	-	-	-	-
EBITDA, 2 Yr. CAGR %	25.49	4.51	-15.95	26.08	45.24
EBITA, 2 Yr. CAGR %	25.15	4.44	-15.85	25.87	44.96
EBIT, 2 Yr. CAGR %	25.15	4.44	-15.85	25.87	44.96
Earnings From Cont. Operations, 2 Yr. CAGR %	27.31	3.74	-15.11	16.67	47.12
Net Income, 2 Yr. CAGR %	27.31	3.74	-15.11	16.67	47.12
Normalized Net Income, 2 Yr. CAGR %	27.31	3.74	-15.11	16.66	47.1
Diluted EPS Before Extra, 2 Yr. CAGR %	27.47	-11.24	-29.79	6.51	36.16
Net Property, Plant and Equip., 2 Yr. CAGR %	132.62	278.41	34.1	-17.02	-21.96
Total Assets, 2 Yr. CAGR %	-44.37	-13.51	15.5	4.47	-28.77
Tangible Book Value, 2 Yr. CAGR %	-26.95	-0.3	-23.72	-72.76	100.8
Common Equity, 2 Yr. CAGR %	-36.84	-0.36	-3.55	-48.48	68.63
Cash From Operations, 2 Yr. CAGR %	13.75	-36.03	-17.27	34.94	22.42
Capital Expenditures, 2 Yr. CAGR %	28.34	-16.24	-10.47	63.78	-44.38
Levered Free Cash Flow, 2 Yr. CAGR %	291.35	-47.41	-2.65	8.05	-34.82
Unlevered Free Cash Flow, 2 Yr. CAGR %	293.12	-47.7	-0.62	8.58	-34.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	-
Gross Profit, 3 Yr. CAGR %	-	-	-	-	-
EBITDA, 3 Yr. CAGR %	-9.82	15.59	-7.68	9.6	24.55
EBITA, 3 Yr. CAGR %	-9.76	15.41	-7.67	9.55	24.39
EBIT, 3 Yr. CAGR %	-9.76	15.41	-7.67	9.55	24.39
Earnings From Cont. Operations, 3 Yr. CAGR %	-12.46	15.36	-6.45	8.84	18.08
Net Income, 3 Yr. CAGR %	-12.46	15.36	-6.45	8.84	18.08
Normalized Net Income, 3 Yr. CAGR %	-8.37	15.36	-6.45	8.84	18.07
Diluted EPS Before Extra, 3 Yr. CAGR %	-13.95	4	-17.53	-7.74	9.7
Net Property, Plant and Equip., 3 Yr. CAGR %	63.96	125.83	129.57	13.59	-19.86
Total Assets, 3 Yr. CAGR %	-37.11	-29.79	-3.73	6.86	-15.41
Tangible Book Value, 3 Yr. CAGR %	-28.71	-28.47	-5.53	-62.94	50.66
Common Equity, 3 Yr. CAGR %	-34.66	-24.97	-4.45	-34.5	35.69
Cash From Operations, 3 Yr. CAGR %	-11.33	-2.1	-27.17	9.7	12.25
Capital Expenditures, 3 Yr. CAGR %	-26.08	-11.24	9.82	4.43	-16.41
Levered Free Cash Flow, 3 Yr. CAGR %	17.76	110.21	-24.39	-7.34	-16.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.19	112.98	-24.39	-6.06	-16.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-
EBITDA, 5 Yr. CAGR %	31.86	15.36	-12.32	15.7	12.25
EBITA, 5 Yr. CAGR %	32.5	15.34	-12.25	15.54	12.16
EBIT, 5 Yr. CAGR %	32.5	15.34	-12.25	15.54	12.16
Earnings From Cont. Operations, 5 Yr. CAGR %	39.73	14.84	-13.53	15.89	12.12
Net Income, 5 Yr. CAGR %	39.73	14.84	-13.53	15.89	12.12
Normalized Net Income, 5 Yr. CAGR %	33.56	14.96	-11.13	15.88	12.12
Diluted EPS Before Extra, 5 Yr. CAGR %	34.08	3.86	-20.67	5	0.79
Net Property, Plant and Equip., 5 Yr. CAGR %	78.2	84.64	51.29	51.31	49.1
Total Assets, 5 Yr. CAGR %	0.75	-12.73	-19.79	-17.69	-14.66
Tangible Book Value, 5 Yr. CAGR %	0.8	23.03	-26.76	-51.38	27.73
Common Equity, 5 Yr. CAGR %	-3.55	26.62	-23.64	-35.45	19.92
Cash From Operations, 5 Yr. CAGR %	27.39	-9.54	-13.75	11.31	-10.36
Capital Expenditures, 5 Yr. CAGR %	65.99	-17.94	-20.19	13.41	-16.34
Levered Free Cash Flow, 5 Yr. CAGR %	22.3	1.96	9.13	64.88	-29.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	21.29	1.71	9.15	66.54	-29.14